| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 15,000 |
-
| | Cost of Revenue |
-
|
-
| | | Gross Profit | 15,000 |
-
| | | Operating Expenses | | Research Development | 2,342 |
-
| | Selling General and Administrative | 21,805 | 12,481 | | Non Recurring |
-
|
-
| | Others | 7,994 | 35 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (17,141) | (12,516) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 18,684 | 52,225 | | Earnings Before Interest And Taxes | 1,543 | 76,145 | | Interest Expense | 79,887 | 88,661 | | Income Before Tax | (78,344) | (12,516) | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (78,344) | (48,952) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (78,344) | (48,952) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($78,344) | ($48,952) |
|
0.51% Nasdaq 
Income Statement
